ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

EDAP EDAP TMS SA

5.18
0.195 (3.91%)
Last Updated: 20:32:23
Delayed by 15 minutes
Share Name Share Symbol Market Type
EDAP TMS SA NASDAQ:EDAP NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.195 3.91% 5.18 5.13 5.27 5.2585 5.00 5.108 28,197 20:32:23

EDAP TMS S.A. to Host Its 2004 Second Quarter Financial Results Conference Call on the Web

22/07/2004 2:00pm

PR Newswire (US)


EDAP TMS (NASDAQ:EDAP)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more EDAP TMS Charts.
EDAP TMS S.A. to Host Its 2004 Second Quarter Financial Results Conference Call on the Web VAULX-EN-VELIN, France, July 22 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (NASDAQ:EDAP), a global leader in the development, marketing and distribution of a portfolio of minimally-invasive medical devices for the treatment of urological diseases, today announced that it will host its 2004 second quarter financial results conference call on the web on Thursday July 29, 2004, following the Company's post-market press release on Wednesday July 28, 2004. Representing the Company on the call will be Philippe Chauveau, Chairman of the Board, Hugues de Bantel, Chief Executive Officer, and Thierry Turbant, Chief Financial Officer. A replay of the call will be available for 7 days on the Company's web site. What: EDAP TMS S.A. 2004 Second Quarter Financial Results Conference Call When: July 29, 2004 - 12:00 noon New York Time Where: http://www.edap-tms.com/ EDAP TMS S.A. is the global leader in the development, production, marketing and distribution of a portfolio of minimally invasive medical devices primarily for the treatment of urological diseases. The Company currently develops and markets devices for the minimally invasive treatment of localized prostate cancer, using High Intensity Focused Ultrasound (HIFU), through its HIFU Division; it is also developing this technology for the treatment of certain other types of tumors. EDAP TMS S.A. also produces and commercializes medical equipment for treatment of urinary tract stones using Extra-corporeal Shockwave Lithotripsy (ESWL), via its Urology Devices and Services (UDS) Division. In addition, the Company markets devices for the non-surgical treatment of benign Prostate Hyperplasia (BPH) using Microwave Thermotherapy (TUMT). For more information on the Company, contact our Investor Relations Dept by phone at +33 (0) 4 78 26 40 46 or please see the Company's web site at: http://www.edap-tms.com/ . This press release contains, in addition to historical information, forward-looking statements that involve risks and uncertainties. These include statements regarding the Company's growth and expansion plans. Such statements are based on management's current expectations and are subject to a number of uncertainties and risks that could cause actual results to differ materially from those described in the forward-looking statements. Factors that may cause such a difference include, but are not limited to, those described in the Company's filings with the Securities and Exchange Commission. CONTACT: Hugues de Bantel / Blandine Confort +33 4 78 26 40 46 DATASOURCE: EDAP TMS S.A. CONTACT: Blandine Confort, +33-4-78-26-40-46, for EDAP TMS S.A. Web site: http://www.edaptechnomed.com/ http://www.edap-tms.com/

Copyright

1 Year EDAP TMS Chart

1 Year EDAP TMS Chart

1 Month EDAP TMS Chart

1 Month EDAP TMS Chart